Literature DB >> 7485725

Impact of clinicopathologic parameters on patient survival in carcinoma of the cervical esophagus.

D J Kelley1, R Wolf, A R Shaha, R H Spiro, M S Bains, D H Kraus, J P Shah.   

Abstract

BACKGROUND: The survival of patients with carcinoma of the cervical esophagus remains poor in spite of multimodality treatment and technical improvements in surgical resection and reconstruction. This study was undertaken to update our experience with cervical esophageal carcinoma and to identify factors that had an impact on patient survival and quality of life. PATIENTS AND METHODS: Clinical data encompassing 132 variables were collected on 67 patients with cervical esophageal carcinoma from 1980 to 1993. Statistical analysis was performed: independent Student's t-tests, Cox regression, Kaplan-Meier curves, and log rank analyses were used in the statistical evaluation. The mean age of the patients was 63 years (range 31 to 88). Dysphagia was the primary symptom in 86% of patients; 80% had received no prior treatment. The most common abnormal finding (21%) on physical examination was a neck mass.
RESULTS: Curative resection was performed in 22 patients, 7 had palliative procedures, and 7 were found to be inoperable at exploration and received palliative treatment. Radiation with or without chemotherapy was definitive treatment for 10 patients, whereas 4 patients were treated with chemotherapy alone for cure, and 17 patients received palliative treatment. The mean survival following diagnosis was 17 months (range 1 to 96). Cumulative 5-year survival was 12%.
CONCLUSIONS: Persistent disease, chemotherapy prior to presentation, and chemotherapy for cure remained as statistically significant parameters associated with decreased survival by multivariate analysis. There was a trend toward improved survival in patients treated with surgical resection.

Entities:  

Mesh:

Year:  1995        PMID: 7485725     DOI: 10.1016/s0002-9610(99)80322-5

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  6 in total

1.  A clinical study of surgical treatment of patients with carcinoma of the cervical esophagus extending to the thoracic esophagus.

Authors:  R Saito; H Suzuki; S Motoyama; S Sasaki; M Okuyama; J Ogawa; M Kitamura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-07

2.  Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer.

Authors:  Shu-Lian Wang; Zhongxing Liao; Helen Liu; Jaffer Ajani; Stephen Swisher; James D Cox; Ritsuko Komaki
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

3.  [The carotid artery as recipient vessel: troubleshooting for free jejunal transfer after esophagectomy in preradiated patients].

Authors:  D F Müller; J A Lohmeyer; A Zimmermann; J R Siewert; L Kovacs; H-G Machens; E Biemer
Journal:  Chirurg       Date:  2011-08       Impact factor: 0.955

4.  Is Direct Laryngoscopy Obsolete? "Trans Nasal Oesophagoscopy" the Complete Endoscopic Solution in Head Neck Practice.

Authors:  P Lakshminarasimman; Prathamesh S Pai; Shaesta Mehta; Prachi Patil
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-01-12

5.  Larynx-preserving limited resection and free jejunal graft for carcinoma of the cervical esophagus.

Authors:  Hiroshi Miyata; Makoto Yamasaki; Tsuyoshi Takahashi; Yukinori Kurokawa; Kiyokazu Nakajima; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  World J Surg       Date:  2013-03       Impact factor: 3.352

6.  Influence of resection extent on morbidity in surgery for squamous cell cancer at the pharyngoesophageal junction.

Authors:  Peter Panhofer; Christopher Springer; Barbara Izay; Matthäus Grasl; Martin Burian; Sebastian F Schoppmann; Thomas Rath; Raimund Jakesz; Johannes Zacherl
Journal:  Langenbecks Arch Surg       Date:  2012-09-02       Impact factor: 3.445

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.